首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Conversion of pancreatic α cells into insulin-producing cells modulated by β-cell insufficiency and supplemental insulin administration
Institution:1. Department of Metabolism and Endocrinology, Japan;2. Center for Identification of Diabetic Therapeutic Targets, Japan;3. Center for Therapeutic Innovations in Diabetes, Juntendo University Graduate School of Medicine, Tokyo, Japan;1. University of Chinese Academy of Sciences, Beijing, 100049, China;2. Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, 300308, China;3. Institute of Biological Chemistry, Academia Sinica, Taipei, 11529, Taiwan;4. State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan, 430062, China;1. Department of Orthopedics, Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China;2. Central Laboratory, Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China;1. Department of Pharmacology, Peripheral Neuropathy Research Center (PNRC), Dong-A University College of Medicine, Busan, 49201, South Korea;2. Department of Biochemistry, Peripheral Neuropathy Research Center (PNRC), Dong-A University College of Medicine, Busan, 49201, South Korea;3. Department of Neurology, SAIHST, Sungkyunkwan University School of Medicine, Seoul, 06351, South Korea;3. From the Department of Metabolic Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan;4. Division of Stem Cell Regulation Research, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan, the;5. Department of Medicine, Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University Medical Center, Nashville, Tennessee 37232-6303, and the;6. Department of Molecular Physiology & Biophysics, Vanderbilt University Medical School, Nashville, Tennessee 37232;1. Flaum Eye Institute, USA;2. Department of Medicine, University of Rochester, Rochester, NY, USA
Abstract:The emergence of bihormonal (BH) cells expressing insulin and glucagon has been reported under diabetic conditions in humans and mice. Whereas lineage tracing studies demonstrated that glucagon-producing α cells can be reprogrammed into BH cells, the underlying dynamics of the conversion process remain poorly understood. In the present study, we investigated the identities of pancreatic endocrine cells by genetic lineage tracing under diabetic conditions. When β-cell ablation was induced by alloxan (ALX), a time-dependent increase in BH cells was subsequently observed. Lineage tracing experiments demonstrated that BH cells originate from α cells, but not from β cells, in ALX-induced diabetic mice. Notably, supplemental insulin administration into diabetic mice resulted in a significant increase in α-cell-derived insulin-producing cells that did not express glucagon. Furthermore, lineage tracing in Ins2Akita diabetic mice demonstrated a significant induction of α-to-β conversion. Thus, adult α cells have plasticity, which enables them to be reprogrammed into insulin-producing cells under diabetic conditions, and this can be modulated by supplemental insulin administration.
Keywords:Bihormonal cell  Glucagon  Insulin  α-To-β conversion  Diabetes
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号